comparemela.com

Latest Breaking News On - Healthcare products regulatory authority - Page 9 : comparemela.com

The Guardian view on the AstraZeneca vaccine: confidence from clarity | Vaccines and immunisation

Where risk is involved, science deals in probabilities not certainties. Communication around vaccines must accept that reality ‘If the balance of risk and benefit is framed accurately, the evidence is irresistible in favour of vaccination.’ Photograph: Christopher Thomond/The Guardian ‘If the balance of risk and benefit is framed accurately, the evidence is irresistible in favour of vaccination.’ Photograph: Christopher Thomond/The Guardian Wed 7 Apr 2021 13.39 EDT Last modified on Fri 9 Apr 2021 09.41 EDT Every day, people take medicines with known side-effects. The risk is accepted when weighed against the benefit. But Covid vaccines are unfamiliar. There is no record of use over time to build public confidence. Still, they have been tested and proven to offer protection against the virus. By all usual medical standards, they are safe. That remains true for the AstraZeneca vaccine, despite an evolving picture that side-effects might include a rare blood clotting disord

The Guardian view on the AstraZeneca vaccine: confidence from clarity

The Guardian view on the AstraZeneca vaccine: confidence from clarity Editorial © Provided by The Guardian Photograph: Jens Kalaene/AP Every day, people take medicines with known side-effects. The risk is accepted when weighed against the benefit. But Covid vaccines are unfamiliar. There is no record of use over time to build public confidence. Still, they have been tested and proven to offer protection against the virus. By all usual medical standards, they are safe. That remains true for the AstraZeneca vaccine, despite an evolving picture that side-effects might include a rare blood clotting disorder. The UK’s Medicines and Healthcare Products Regulatory Authority is still investigating the link, but has recommended, as a precaution, that other vaccines be preferred for recipients under 30. That is a notable shift in policy when ministers have dismissed any talk of risks associated with the jab. The European Medicines Agency on Wednesday recommended that

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

The Netherlands has joined Ireland in suspending use of the Oxford/AstraZeneca coronavirus vaccine as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. Announcing the move late on Sunday, the Dutch health ministry said there was no proof yet of a direct link between the vaccine and reports of possible side effects from Norway and Denmark and it had not recorded any cases in.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.